Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

July 2023

Le tofacitinib réduit l'inflammation spinale dans les corps vertébraux et les éléments postéro-latéraux dans la spondylarthrite ankylosante : Résultats d'un essai de phase 2

Rheumatol Ther. 2023;10(4):1001–1020 doi 10.1007/s40744-023-00564-y

Wu J,

Wang C,

Tofacitinib treatment is associated with a significant improvement in CANDEN MRI scores of spinal inflammation in axSpA patients. This study by Østergaard, et al. also validates the CANDEN MRI scoring system as an approach for measuring axSpA-associated inflammatory lesions.

Keywords:

June 2022

Le filgotinib diminue l'inflammation du corps vertébral et de la colonne postéro-latérale dans la spondylarthrite ankylosante : Résultats de l'essai TORTUGA

Rheumatology 2022;61:2388–2397. doi: 10.1093/rheumatology/keab758

Liu K,

Besuyen R and Baraliakos X

Maksymowych et al., assessed the effects of filgotinib on inflammatory and structural changes at various spinal locations, based on MRI measures in patients with active ankylosing spondylitis in the TORTUGA trial. Correlations between changes in the inflammation score and clinical outcomes were also evaluated.